CO [China Cord Blood] SC 13G/A: SCHEDULE 13G/A Amendment No. 13 China Cord Blood

[SCHEDULE 13G/A Amendment No. 13 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *T]

By | 2018-02-15T03:00:44+00:00 February 14th, 2018|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13G/A: (Original Filing)

[SCHEDULE 13G/A Amendment No. 13 China Cord Blood Corporation (Name of Issuer) Common Stock, par value $0.0001 per share (Title of Class of Securities) 698659109 (CUSIP Number) December 31, 2017 (Date of Event Which Requires Filing of this Statement) ☐ Rule 13d-1(b) ☒ Rule 13d-1(c) ☐ Rule 13d-1(d) *T]

By | 2018-02-15T03:00:39+00:00 February 14th, 2018|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D: (Original Filing)

[JOINT FILING AGREEMENT This Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute but one agreement. th Blue Ocean Structure Investment Co Ltd Ping Xu Director Nanjing Yin]

By | 2018-02-08T14:02:11+00:00 February 8th, 2018|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] SC 13D: JOINT FILING AGREEMENT This Joint Filing Agreement may

[JOINT FILING AGREEMENT This Joint Filing Agreement may be executed in one or more counterparts, each of which shall be deemed to be an original instrument, but all of such counterparts together shall constitute but one agreement. th Blue Ocean Structure Investment Co Ltd Ping Xu Director Nanjing Yin]

By | 2018-02-08T14:02:15+00:00 February 8th, 2018|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[Nanjing Ying Peng Becomes Major Shareholder of China Cord Blood Corporation HONG KONG, China, January 31, 2018 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), a leading cord blood bank operator in China, today announced that Nanjing Ying Peng Hui Kang Medical Industry Investment]

By | 2018-01-31T14:00:43+00:00 January 31st, 2018|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: Nanjing Ying Peng Becomes Major Shareholder of China

[Nanjing Ying Peng Becomes Major Shareholder of China Cord Blood Corporation HONG KONG, China, January 31, 2018 — China Cord Blood Corporation (NYSE: CO) (“CCBC” or the “Company”), a leading cord blood bank operator in China, today announced that Nanjing Ying Peng Hui Kang Medical Industry Investment]

By | 2018-01-31T14:00:48+00:00 January 31st, 2018|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: (Original Filing)

[China Cord Blood Corporation Announces Results of 201 7 Annual General Meeting HONG KONG, China, December 7 , 201 7 - China Cord Blood Corporation At the Annual General Meeting, shareholders · · About China Cord Blood Corporation China Cord Blood Corporation is the first and largest umbilical cord b]

By | 2017-12-10T07:15:06+00:00 December 7th, 2017|Categories: Chinese Stocks, CO, SEC Original|Tags: , , , , , |0 Comments

CO [China Cord Blood] 6-K: China Cord Blood Corporation Announces Results of 201

[China Cord Blood Corporation Announces Results of 201 7 Annual General Meeting HONG KONG, China, December 7 , 201 7 - China Cord Blood Corporation At the Annual General Meeting, shareholders · · About China Cord Blood Corporation China Cord Blood Corporation is the first and largest umbilical cord b]

By | 2017-12-10T07:15:09+00:00 December 7th, 2017|Categories: Chinese Stocks, CO, Webplus ver|Tags: , , , , , |0 Comments
Skip to toolbar